Hematologic Malignancies Clinical Trials in Georgia

Cancer Type = Hematologic Malignancies

Cancer Type = Hematologic Malignancies

There are currently 4 active Hematologic Malignancies clinical trials in Georgia.
1.
A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) (FIRM)
Cancer Type
Hematologic Malignancies
NCI ID
NCT02694978
Protocol IDs
AMAG-FER-IDA-304
2.
Modular Phase II Study to Link Targeted Therapy to Patients With Pathway Activated Tumors: Module 4 - LGX818 for Patients With BRAFV600 Mutated Tumors
Cancer Type
Hematologic Malignancies
NCI ID
NCT01981187
Protocol IDs
CLGX818AUS03
Treatment Sites (1)
3.
Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Cancer Type
Hematologic Malignancies
NCI ID
NCT02252159
Protocol IDs
INCB-MA-PV-401
4.
NCORP Trial
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries
Cancer Type
Hematologic Malignancies
NCI ID
NCT01166009
Protocol IDs
NMDP IRB-1999-0021
Treatment Sites (1)
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.